Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03895814 · ClinicalTrials.gov registry record · NA

Protective Step Training in Parkinson's Disease

A NA study of Parkinson Disease, sponsored by Arizona State University.

Completed
Registry status
NA
Development phase
35
Enrollment target
1
Study location

NCT03895814: Completed NA study of Parkinson Disease, sponsored by Arizona State University.

NCT03895814 is a NA study of Parkinson Disease that has completed, run by Arizona State University. The registered enrollment target is 35 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03895814, a NA study of Parkinson Disease, has completed, sponsored by Arizona State University.

COMPLETED
Registry status
NA
Development phase
35 participants
Enrollment target
1
Study location

Study Summary

The primary purpose of this project is to determine the preliminary effectiveness of protective step training to improve balance and reduce falls in people with Parkinson's disease (PD) and postural disturbances. A secondary purpose is to understand which baseline patient characteristics predict responsiveness to treatment. By informing 1) the effectiveness of a promising rehabilitative intervention, and 2) the selection of the participants that will be most responsive to treatment, these data may enhance clinicians' ability to treat balance disturbances in people with PD. Importantly, protective step training, described in this proposal, can be quickly deployed in the clinic at minimal cost. Therefore, if shown to be effective via this and subsequent trials, this approach can be easily integrated into care, immediately impacting a large number of people with PD.

Primary Outcome

MOS: Distance between the extrapolated center of mass and base of support at first foot contact after the slip

Conditions Studied

Interventions

  • BEHAVIORAL Protective Step Training

Study Locations (1)

Arizona

  • Arizona State University - Phoenix

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2019-06-01
Est. Completion 2022-06-01
Phase NA
Arizona State University

187 total trials

What the finished NCT03895814 record still lists

NCT03895814 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which Protective Step Training is the first listed.

NCT03895814 reports a single indexed study location in Arizona.

Frequently Asked Questions

What is clinical trial NCT03895814 about?

NCT03895814 is a clinical study titled "Protective Step Training in Parkinson's Disease". The primary purpose of this project is to determine the preliminary effectiveness of protective step training to improve balance and reduce falls in people with Parkinson's disease (PD) and postural disturbances. A secondary purpose is to understand which baseline patient characteristics predict res...

What is the current status of trial NCT03895814?

This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2019-06-01. Estimated completion is 2022-06-01.

What conditions does trial NCT03895814 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT03895814?

The interventions under investigation include: Protective Step Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT03895814?

This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03895814 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03895814's enrollment target sits among peer trials

35 194th of 297 higher than 102 of 297 other Parkinson Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Parkinson Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01697371 · 35 participants · NA

    Proton Therapy in the Treatment of Liver Metastases

  • NCT01940757 · 35 participants · Phase 1

    Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae

  • NCT02235857 · 35 participants · NA

    Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children

  • NCT02637934 · 35 participants · Phase 1

    Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03895814, the US trial registry maintained by the National Library of Medicine. NCT03895814 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.